SKI Market

A+| A| A-|

Indian Indices

Sensex

74,326.37 -19.80
( -0.03%)

Global Indices

Nasdaq

50,746.98 -581.81
(-1.13%)

Dow Jones

7,576.82 -53.96
(-0.71%)

Hang Seng

68,675.29 1,941.05
(2.91%)

Nikkei 225

10,340.87 -32.64
(-0.31%)

Forex

USD-INR

95.24 0.16
(0.17%)

EUR-INR

110.83 0.16
(0.15%)

GBP-INR

128.25 0.32
(0.25%)

JPY-INR

0.60 0.00
(0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Gujarat Themis Biosyn Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

506879

INE942C01045

26.4090145

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GUJTHEM

93.87

4377.68

EPS(TTM)

Face Value()

Div & Yield %

4.28

0.17

Back

Rallis India standalone net profit declines 81.82% in the December 2025 quarter

Jan 21,2026

Net profit of Rallis India declined 81.82% to Rs 2.00 crore in the quarter ended December 2025 as against Rs 11.00 crore during the previous quarter ended December 2024. Sales rose 19.35% to Rs 623.00 crore in the quarter ended December 2025 as against Rs 522.00 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	623.00	522.00	19
OPM %	9.31	8.43	-
PBDT	65.00	48.00	35
PBT	36.00	19.00	89
NP	2.00	11.00	-82

74,326.37 -19.80 ( -0.03%)

50,746.98 -581.81 (-1.13%)

7,576.82 -53.96 (-0.71%)

68,675.29 1,941.05 (2.91%)

10,340.87 -32.64 (-0.31%)

95.24 0.16 (0.17%)

110.83 0.16 (0.15%)

128.25 0.32 (0.25%)

0.60 0.00 (0.02%)